Krystal Biotech, Inc.
US ˙ NasdaqGS ˙ US5011471027

SecurityKRYS / Krystal Biotech, Inc.
InstitutionAlps Advisors Inc
Latest Disclosed Ownership2,000 shares
Latest Disclosed Value $ 516,640
Alps Advisors Inc ownership in KRYS / Krystal Biotech, Inc.

On May 8, 2026 - Alps Advisors Inc filed a 13F-HR form disclosing ownership of 2,000 shares of Krystal Biotech, Inc. (US:KRYS) valued at $516,640 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 0 shares of Krystal Biotech, Inc.. The current value of the position is $603,640 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F KRYSTAL BIOTECH COM 501147102 2,000 2,000 517 0.0022
2026-02-12 2025-12-31 13F KRYSTAL BIOTECH COM 501147102 0 -13,367 -100.00 0 -100.00
2025-11-05 2025-09-30 13F KRYSTAL BIOTECH COM 501147102 13,367 -4,095 -23.45 2,360 -1.71 0.0131
2025-08-11 2025-06-30 13F KRYSTAL BIOTECH COM 501147102 17,462 15,542 809.48 2,400 593.64 0.0138
2025-04-30 2025-03-31 13F KRYSTAL BIOTECH COM 501147102 1,920 1,920 346 0.0020
2025-02-13 2024-12-31 13F KRYSTAL BIOTECH COM 501147102 0 -22,372 -100.00 0 -100.00
2024-11-12 2024-09-30 13F KRYSTAL BIOTECH COM 501147102 22,372 102 0.46 4,072 -0.42 0.0273
2024-08-13 2024-06-30 13F KRYSTAL BIOTECH COM 501147102 22,270 22,270 4,090 0.0281
2024-02-14 2023-12-31 13F KRYSTAL BIOTECH COM 501147102 0 -20,620 -100.00 0 -100.00
2023-11-14 2023-09-30 13F KRYSTAL BIOTECH COM 501147102 20,620 384 1.90 2,392 0.67 0.0199
2023-08-14 2023-06-30 13F KRYSTAL BIOTECH COM 501147102 20,236 3,259 19.20 2,376 74.76 0.0206
2023-05-10 2023-03-31 13F KRYSTAL BIOTECH COM 501147102 16,977 -467 -2.68 1,359 -1.59 0.0120
2023-02-14 2022-12-31 13F KRYSTAL BIOTECH COM 501147102 17,444 3,403 24.24 1,382 41.06 0.0123
2022-11-14 2022-09-30 13F KRYSTAL BIOTECH COM 501147102 14,041 -1,170 -7.69 979 -2.00 0.0093
2022-08-15 2022-06-30 13F/A-1 KRYSTAL BIOTECH COM 501147102 15,211 -10,702 -41.30 999 -42.05 0.0097
2022-08-11 2022-06-30 13F KRYSTAL BIOTECH COM 501147102 15,211 -10,702 999 0.0096
2022-05-16 2022-03-31 13F KRYSTAL BIOTECH COM 501147102 25,913 -2,906 -10.08 1,724 -14.48 0.0187
2022-02-09 2021-12-31 13F KRYSTAL BIOTECH COM 501147102 28,819 1,606 5.90 2,016 41.87 0.0227
2021-11-15 2021-09-30 13F KRYSTAL BIOTECH COM 501147102 27,213 -2,028 -6.94 1,421 -28.52 0.0137
2021-08-11 2021-06-30 13F KRYSTAL BIOTECH COM 501147102 29,241 -6,413 -17.99 1,988 -27.63 0.0176
2021-05-07 2021-03-31 13F KRYSTAL BIOTECH COM 501147102 35,654 111 0.31 2,747 28.79 0.0268
2021-02-03 2020-12-31 13F KRYSTAL BIOTECH COM 501147102 35,543 10,467 41.74 2,133 97.50 0.0240
2020-11-05 2020-09-30 13F/A-1 KRYSTAL BIOTECH COM 501147102 25,076 1,357 5.72 1,080 9.98 0.0159
2020-11-04 2020-09-30 13F KRYSTAL BIOTECH COM 501147102 25,076 1,357 1,080 13,841.4939
2020-08-05 2020-06-30 13F KRYSTAL BIOTECH COM 501147102 23,719 -7,751 -24.63 982 -27.85 0.0132
2020-05-06 2020-03-31 13F KRYSTAL BIOTECH COM 501147102 31,470 -3,366 -9.66 1,361 -29.45 0.0211
2020-02-07 2019-12-31 13F KRYSTAL BIOTECH COM 501147102 34,836 348 1.01 1,929 61.02 0.0150
2019-11-04 2019-09-30 13F KRYSTAL BIOTECH COMMON STOCK 501147102 34,488 4,260 14.09 1,198 -1.56 0.0093
2019-08-07 2019-06-30 13F KRYSTAL BIOTECH COMMON STOCK 501147102 30,228 -4,623 -13.27 1,217 6.10 0.0090
2019-05-01 2019-03-31 13F KRYSTAL BIOTECH COMMON STOCK 501147102 34,851 1,507 4.52 1,147 65.51 0.0081
2019-02-04 2018-12-31 13F KRYSTAL BIOTECH COMMON STOCK 501147102 33,344 33,344 693 0.0054
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.